Holen Sie sich die Stockscreener-App
1.35
0.00%
0.00
Schlusskurs vom Vortag:
$1.35
Offen:
$1.34
24-Stunden-Volumen:
93,275
Relative Volume:
0.16
Marktkapitalisierung:
$173.15M
Einnahmen:
$272.07M
Nettoeinkommen (Verlust:
$-248.06M
KGV:
-0.6694
EPS:
-2.0167
Netto-Cashflow:
$-16.48M
1W Leistung:
-2.88%
1M Leistung:
-24.58%
6M Leistung:
-25.00%
1J Leistung:
-26.63%
1-Tages-Spanne:
$1.29
$1.37
1-Wochen-Bereich:
$1.275
$1.425
52-Wochen-Spanne:
$0.72
$3.22
Waldencast Plc Stock (WALD) Company Profile
Firmenname
Waldencast Plc
Sektor
Telefon
(917) 546-6828
Adresse
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, CCL, KVUE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
1.35 | 164.17M | 272.07M | -248.06M | -16.48M | -2.0167 |
PG
Procter Gamble Co
|
144.55 | 334.90B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
62.09 | 132.90B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
91.95 | 73.59B | 20.80B | 2.22B | 3.77B | 2.5772 |
CCL
Colgate Palmolive Co
|
28.12 | 37.90B | 26.98B | 3.10B | 2.98B | 2.2492 |
KVUE
Kenvue Inc
|
19.20 | 36.46B | 15.29B | 1.62B | 1.82B | 0.8433 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-14 | Fortgesetzt | Jefferies | Buy |
| 2025-11-25 | Herabstufung | Telsey Advisory Group | Outperform → Market Perform |
| 2025-04-22 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-12-16 | Eingeleitet | TD Cowen | Hold |
| 2024-10-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-01 | Bestätigt | Telsey Advisory Group | Outperform |
| 2023-07-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
Alle ansehen
Waldencast Plc Aktie (WALD) Neueste Nachrichten
Waldencast PLC (NASDAQ:WALD) Short Interest Up 121.7% in July - marketbeat.com
Waldencast plc (WALD) repurchases 193,816 RSUs as Hind Sebti moves to Obagi - Stock Titan
Waldencast PLC (WALD) Stock News Today - TradingKey
Waldencast PLC (WALD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Waldencast plc (WAL - natlawreview.com
Waldencast PLC (WALD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Waldencast Shareholders Back Board, Auditor and Five-Year Share Buyback Authority - TipRanks
Waldencast (WALD) investors approve directors, auditor and share repurchase - Stock Titan
Waldencast (WALD) Edges Higher: Beauty Stock Approaches Key Resistance at $1.82Merger Arbitrage - dars.gov.et
Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint - The Manila Times
Waldencast (NASDAQ: WALD) completes Obagi sale valued up to $460M - Stock Titan
Waldencast plc Revenue Breakdown – NASDAQ:WALD - TradingView
Waldencast Finalizes Obagi Medical Sale, Refocuses on Milk Makeup and Repays Debt - TipRanks
Waldencast Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Waldencast PLC (WALD) Balance Sheet - TradingKey
Waldencast Hits Indicted Obagi Ex-CEO With 9-Figure Fraud Case - Bloomberg Law News
Waldencast PLC (WALD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waldencast PLC (WALD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Waldencast PLC (WALD) Cash Flow - TradingKey
Waldencast PLC (WALD) Income Statement - TradingKey
Waldencast PLC (WALD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
WALD|Waldencast PLC|Price:1.720|Chg%:+0.030 - TradingKey
WALD|Waldencast PLC|Price:1.690| - TradingKey
WALD|Waldencast PLC|Price:1.730|Chg%:+0.040 - TradingKey
Waldencast (WALD) Q4 2024 earnings summary - Quartr
Waldencast Company Profile & Introduction - Moomoo
Waldencast PLC (WALD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
WALD Q4 2024 Earnings: Significant EPS Miss Raises ConcernsEarnings Revision Downgrade - dars.gov.et
WALD|Waldencast PLC|Price:1.675|Chg%:-0.045 - TradingKey
Waldencast plc (WALD) Q4 2024 Earnings: EPS Misses Estimates by a Wide Margin, Yet Shares RiseEPS Revision Trend - dars.gov.et
Waldencast Q4 2024 Earnings: EPS Misses Estimates as Stock Rises Despite Wide LossEPS Guidance Update - dars.gov.et
WALD Q4 2024 Earnings: Significant EPS Miss Amidst Operational ChallengesAnalyst Earnings Estimate - dars.gov.et
Price to sales forward of Waldencast plc – NASDAQ:WALD - TradingView
Price to book forward of Waldencast plc – NASDAQ:WALD - TradingView
Enterprise value to EBIT forward of Waldencast plc – NASDAQ:WALD - TradingView
Price to earnings forward of Waldencast plc – NASDAQ:WALD - TradingView
Waldencast (WALD) Slips 1.17% as Stock Hovers Near Key Support LevelChandelier Stop - dars.gov.et
Discover TROOPS And 2 Other Promising Penny Stocks - Sahm
Waldencast (WALD) Q4 2024 Earnings: EPS Misses Estimates as Revenue Details Remain UndisclosedEarnings Growth Analysis - dars.gov.et
Waldencast Sets August AGM as Board Reshapes Around Milk Makeup Focus - TipRanks
[6-K] Waldencast plc Current Report (Foreign Issuer) | WALD SEC FilingForm 6-K - Stock Titan
Short Interest in Waldencast PLC (NASDAQ:WALD) Drops By 84.6% - MarketBeat
Waldencast Q4 2024 Earnings: Significant EPS Miss Amidst Strategic ChallengesBuyback Announcement Report - dars.gov.et
Waldencast (WALD) Edges Higher Amid Consolidation Near Key SupportLiquidity Order Flow - dars.gov.et
WALD Q4 2024 Earnings: EPS Misses by Wide Margin, Stock DeclinesPost-Announcement Reaction - dars.gov.et
Waldencast plc (WALD) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review
Waldencast plc Warrant Financial Disclosures & SEC Filings - TradingView
Waldencast plc Q4 2024 Earnings: Wide Earnings Miss Sends Stock LowerROIC Trend Report - dars.gov.et
Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States - NTB Kommunikasjon
WALD Stock Price and Chart — NASDAQ:WALD - TradingView
Price to earnings forward of Waldencast plc – NASDAQ:WALDW - TradingView
Finanzdaten der Waldencast Plc-Aktie (WALD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):